De Novo device
EyeBOX (Model EBX-4)
Oculogica, Inc. · Brain Injury Adjunctive Interpretive Oculomotor Assessment Aid (QEA, Class II) · First FDA decision Dec 28, 2018, newest Dec 22, 2021Traumatic brain injury and concussion
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
4
De Novo pathway
Device trials
3
Naming "EyeBOX"
MAUDE reports
0
Brand "EyeBOX", since 2015
PubMed studies
97
Mentioning "EyeBOX"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing EyeBOX (Model EBX-4)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 4 of 4 decisions filed under this name.
- EyeBOX (Model EBX-4)510(k)
K212310 · Decided Dec 22, 2021 · 152 days after receipt
Device type: Brain Injury Adjunctive Interpretive Oculomotor Assessment Aid (QEA) · Neurology & Neurosurgery
- EyeBOX510(k)
K201841 · Decided Sep 6, 2020 · 66 days after receipt
Device type: Brain Injury Adjunctive Interpretive Oculomotor Assessment Aid (QEA) · Neurology & Neurosurgery
- EyeBOX510(k)
K191183 · Decided Jul 31, 2019 · 90 days after receipt
Device type: Brain Injury Adjunctive Interpretive Oculomotor Assessment Aid (QEA) · Neurology & Neurosurgery
1 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "EyeBOX", any status and sponsor, newest update first.
- A Highly Portable Device for Assessment of Mild Traumatic Brain Injury in Deployed and Far-Forward SettingsEnrolling by invitation
Oculogica, Inc.Not on our public-company list
NCT05527041 · 1,600 participants (planned) · Start Jul 1, 2023 · Primary completion Aug 1, 2025
Device: EyeBOX Lens (EBLens) · For: Concussion, Brain; Mild Traumatic Brain Injury
Sites: West Point, New York
- Oculomotor Assessment of Traumatic Brain Injury (TBI)Pivotal-lookingCompleted
Walter Reed National Military Medical CenterFederal agency
NCT03156010 · 201 participants · Start Sep 18, 2017 · Primary completion Apr 19, 2023
Device: Neuro Kinetics IPAS; Oculogica EyeBox and 1 more · For: Traumatic Brain Injury
Sites: Bethesda, Maryland
- Use of Eye Movement Tracking to Detect Oculomotor Abnormality in Traumatic Brain Injury PatientsCompleted
Oculogica, Inc.Not on our public-company list
NCT02776462 · 321 participants · Start Jun 2016 · Primary completion Nov 16, 2017
Device: EyeBox CNS · For: Brain Concussion; Cerebral Concussion; Concussion, Intermediate and 5 more
Sites: Lone Tree, Colorado; Beaver Dam, Wisconsin
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "EyeBOX", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code QEA
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "EyeBOX"[tiab]. The summary above synthesizes these.
- A perceptual eyebox for near-eye displays.
Cholewiak SA, Başgöze Z, Cakmakci O, et al. · Opt Express · 2020
- Eyebox expansion with accurate hologram generation for wide-angle holographic near-eye display.
Chlipala M, Martinez-Carranza J, Idicula MS, et al. · Opt Express · 2023
- Eyebox uniformity optimization over the full field of view for optical waveguide displays based on linked list processing.
Yan S, Zhang E, Guo J, et al. · Opt Express · 2022
- Rapid eyebox measurement for augmented reality waveguides.
Kerst T, Bitarafan MH, Jokinen L, et al. · Appl Opt · 2023
- Adjustable and continuous eyebox replication for a holographic Maxwellian near-eye display.
Zhang S, Zhang Z, Liu J · Opt Lett · 2022
- Eyebox enlargement in holographic AR glasses.
Kalinina A, Putilin A, Kopenkin S · Appl Opt · 2023
- Multi-illumination-interfered Neural Holography with Expanded Eyebox.
Xia X, Mi P, Tao Y, et al. · IEEE Trans Vis Comput Graph · 2025
- Dynamic Eyebox Steering for Improved Pinlight AR Near-Eye Displays.
Xia X, Yu Z, Qiu D, et al. · IEEE Trans Vis Comput Graph · 2025
- Large Depth-of-Field, Large Eyebox, and Wide Field-of-View Freeform-Holographic Augmented Reality Near-Eye Display.
Wang Y, Yang T, Lyu X, et al. · Adv Sci (Weinh) · 2025
- Exploring angular-steering illumination-based eyebox expansion for holographic displays.
Xia X, Wang W, Guan F, et al. · Opt Express · 2023
- Waveguide holography for 3D augmented reality glasses.
Jang C, Bang K, Chae M, et al. · Nat Commun · 2024
- Large-angle two-dimensional grating with hybrid mechanisms.
Zou J, He Z, Yang Q, et al. · Opt Lett · 2021
Other devices of this type
Also filed under product code QEA.
- EyeBOX SNAPOculogica, Inc. · 510(k) 2026
- EyeBOX EBX-4.1Oculogica, Inc. · 510(k) 2025
- Eye-SyncSyncthink, Inc. · 510(k) 2021
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.